Ovarian cancer
Conditions
Interventions
Sponsors
Chengdu Women's and Children's Central Hospital
Eligibility
Sex/Gender
Female
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Initial treatment of ovarian cancer (including rare types of ovarian tumors); 2) Used for neoadjuvant chemotherapy and second HIPEC after intermittent cytoreductive surgery. 3) Patients with epithelial ovarian cancer diagnosed by postoperative histopathology; 4) Estimated survival time >= 6 months; 5) Informed consent of the patient and family members, and signed informed consent form for hyperthermic perfusion.
Exclusion criteria
Exclusion criteria: 1) Intestinal obstruction, extensive adhesions in the peritoneal cavity, and obvious inflammation in the abdominal cavity; 2) There may be a high risk of poor postoperative anastomotic healing; Factors, including anastomotic tissue edema, ischemia, obvious tension, severe hypoproteinemia, etc.; 3) Major organ dysfunction such as heart, kidney, liver, and brain; 4) Severe coagulation dysfunction; bile obstruction and ureteral obstruction; 5) Aged >= 75 years old is a relative contraindication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life; | — |
Secondary
| Measure | Time frame |
|---|---|
| Imaging data;Tumor markers;Drug side effects; | — |
Countries
China
Contacts
Public ContactChen Ying
Chengdu Women's and Children's Central Hospital
Outcome results
None listed